Paul Turgeon, MD
Ophthalmology · Canton, OHNPI 1386643104
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $9,750 of the $13,731 with a category attached, or 71.0%. Ivantis, Inc accounts for 75.9% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $8,544 and has fallen 91.4% since, to $739 in 2025. Among ophthalmology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 95 payments — averaging $144.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ivantis, Inc$10K
- Alcon$2K
- AbbVie$612
- Johnson & Johnson Surgical Vision, Inc.$282
- Amgen$206
- Glaukos Corporation$150
- plus $429 from 6 others
What the payments were for
- Consulting fees$9,75071%
- Speaking & faculty fees$180%
- Travel & lodging$6425%
- Food & beverage$3,27724%
- Gifts$450%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ivantis, Inc | 17 | $10,423 |
| Alcon | 31 | $1,630 |
| AbbVie(2 entities) | 15 | $612 |
| Johnson & Johnson Surgical Vision, Inc. | 4 | $282 |
| Amgen | 6 | $206 |
| Glaukos Corporation | 1 | $150 |
| NEW World Medical,inc. | 10 | $120 |
| Carl Zeiss Meditec, Inc. | 2 | $118 |
| Sight Sciences, Inc. | 5 | $99 |
| Johnson & Johnson Vision Care, Inc. | 1 | $39 |
| Oyster Point Pharma, Inc. | 2 | $35 |
| Bausch & Lomb Americas Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Hydrus Microstent$8,227
- Hydrus$2,250
- AcrySof$574
- iStent inject W$150
- XEN$138
- Tecnis IOL$132
- TEPEZZA$123
- Centurion$114
- Catalys Laser System$103
How this compares
$13,731 in reported general payments places this provider in the 90th percentile of 640 ophthalmology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 19 | $20,084 |
| Prednisolone Acetate | 415 | $16,244 |
| LumiganBimatoprost | 33 | $15,513 |
| Cyclosporine | 17 | $13,339 |
| VyzultaLatanoprostene Bunod | 27 | $8,101 |
| Loteprednol Etabonate | 59 | $7,507 |
| Brimonidine Tartrate | 132 | $4,652 |
| Latanoprost | 323 | $3,750 |
| Travoprost | 23 | $2,760 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 16 | $2,432 |
| Timolol Maleate | 124 | $1,765 |
| Bimatoprost | 12 | $1,761 |
| Ofloxacin | 121 | $1,207 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 99 | $1,150 |
| Atropine Sulfate | 35 | $1,100 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan | $612 | $35,59752 claims |
| Bausch & Lomb Americas Inc.Vyzulta | $18 | $8,10127 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 640 ophthalmology providers in Ohio.
Other ophthalmology in Canton
- Peter KaiserCleveland$1.5M
- Gregory EippertMentor$813K
- Robert OsherCincinnati$720K
- Justis EhlersCleveland$639K
- Lawrence SingermanBeachwood$599K
- Darrell WhiteWestlake$587K
- Alice EpitropoulosColumbus$531K
- Amy MillerDayton$526K
- Sunil SrivastavaCleveland$508K
- William WileyCleveland$479K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.